Background: The contribution of cardiovascular events to the extraordinary high mortality in end-stage-renal disease (ESRD) has generated some interest in non traditional athero sclerotic cardiovascular diseaserisk factors that are prevalent in ESRD , such as Lipoprotein(a) [Lp(a)]. In this study we aimed to consider the association of serum lipoproein(a)) with left ventricular hypertrophy (LVH) and hypertention (HTN) in ESRD patients under regular hemodialysis .
INTRODUCTION
The contribution of cardiovascular events to the extraordinary high mortality in end-stage-renal disease (ESRD) has generated some interest in non traditional athero sclerotic cardiovascular disease( ASCVD) risk factors that are prevalent in ESRD , such as Lipoprotein(a) [Lp(a)] ( 1 ). Lp(a) , which is the most complex and polymorphic of the Lipoprotein particles , is formed by an LDL moiety and a unique protein, apo (a) linked to apolipoprotein (apo) B-100 of LDL ( 2 ). Lp(a) is an independent risk factor for coronary heart disease (CAD) by inducing premature atherosclerosis but the exact mechanism by which Lp(a) confers cardiovasular risk is unknown. Both proathengenic and prothrombogenic effects have been hypothesized ( 3 ).
Elevated plasma Lp(a) levels in chronic renal failure patients have been associated with a frequency distribution of apolipoprotein(a) [apo(a)] isoforms similar to those found in general population. Ts indicates that elevated Lp(a) levels in these patients are not due to genetic origin ( 4 , 5 ). Trefore, it has been suggested that kidneys have an important role in Lp(a) metabolism, decrease Lp(a) catabolism or increase of liver production ( 4 , 5 , 6 , 7 , 8 ). Cardiovascular disease is the principal cause of morbidly and mortality in dialysis patients ( 9 ). A principle findings of cardiovascular disease is left ventricular hypertrophy (LVH) determined by echocardiography ( 9 ). Left ventricular hypertrophy (LVH) is common and as LVH by itself is indepenclent risk factor for cardiovascular disease in hemodialysis (HD) patients ( 10 ).
HD Patients have been associated with elevation of Serum Lp(a) levels( 7 , 11 ) However, relatively little has been published on the link between Lp(a) and cardiovascular disease respectively LVH and LV ejection fraction in HD patients. We therefore sough to evaluate the association of serum level of Lp(a) with left ventricular hypertrophy, LV ejection fraction and chest pain in a group of ESRDhemodialyzed patients consisting of diabetics and nondiabetics.
PATIENTS AND METHODS
This is a cross-sectional study. It was performed on 61 patients with end-stage renal disease (ESRD), undergoing maintenance hemodialysis treatment between September 2002 and December 2003. Patient selection exclusion criteria were cigarette smoking, body mass index (BMI) more than 25, anti lipid drugs taking, recent MI and vascular diseases as well as active or chronic infection and pericarditis or pericardial effusion in echocardiography. For all subjects lipoprotein (a) was measured by enzyme immuno assay (ELISA) by Immuno-Biological laboratories (IBL) kit (Germany). According to the sixth and seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure we stratified hypertensive patients from stage one to three ( 12 , 13 ), (stage of zero equal to no HTN). Stages of the hypertension of HD patients were considered before treatment and at the first start of hemodialysis treatment. I regard to heart echocardiography (B-mode) one single cardiologist who was unaware of the patients data performed all echographies for left ventricular hypertrophy, on the base of sepal thickness. We stratified the patients into no LVH (septal thickness between 6-11 mm), mild (septal thickness between 11-15 mm), moderate (septal thickness between 15-18 mm) and severe LVH (septal thickness >18 mm). LVH measurements were done at the end diastolic phase. LV ejection fraction between 55 and 75% was considered normal. For statistical analysis descriptive data were expressed as mean± SD. Comparison between groups were performed using chi-square(χ 2 test), Mann Whitney as well as 
